hongyan li

Ms. hongyan li

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2023 in Food and Agricultural Immunology
Verified
Journal Article
Open access
HLhongyan li
hongyan li
ZHZhihe Hu
Zhihe Hu
YYYali Yan
Yali Yan

29 January 2026 in Applied Food Research
Verified
Journal Article
Open access
HLhongyan li
hongyan li
QZQixin Zheng
Qixin Zheng
XFXiaoran Fan
Xiaoran Fan

18 February 2026 in Molecules
Verified
Journal Article
Open access
PDF file
BLBingjuan Li
Bingjuan Li
JZJiaojiao Zhuo
Jiaojiao Zhuo
MTMeng-Ran Tian
Meng-Ran Tian
DMDan Meng
Dan Meng
HLhongyan li
hongyan li
As an isoflavone metabolite with diverse physiological activities, the development of efficient and sustainable manufacturing technologies for (S)-equol holds significant importance. This study focuses on the semi-rational design of daidzein reductase (DZNR), the first key enzyme in the (S)-equol biotransformation pathway. Through multiple sequence alignment and three-dimensional structural analysis, two critical residues, Gly30 and Ala105, were identified in DZNR. A library of single and combinatorial mutants was constructed and screened, yielding the double variant DZNR30S+105S with substantially enhanced catalytic performance. In a whole-cell biocatalytic system, the recombinant E. coli (Escherichia coli) strain harboring this combinatorial mutant achieved a yield of 238.3 mg/L (S)-equol at a substrate concentration of 1 mM daidzein, demonstrating markedly improved catalytic efficiency. Upon increasing the daidzein concentration to 2 mM, the reaction reached equilibrium within 5 h, producing 384.6 mg/L (S)-equol, which highlights the mutant’s excellent potential for high-substrate-concentration applications. This study not only provides novel mechanistic insights into DZNR catalysis but also successfully establishes a DZNR variant with enhanced activity, offering an efficient biocatalytic component for the industrial-scale biomanufacturing of (S)-equol and thereby advancing the development of green biosynthesis technologies for this valuable compound.